Fig. 3: Long-term recovery-group trajectories for biologic parameters (n = 113 CovPs).
From: A patient-centric modeling framework captures recovery from SARS-CoV-2 infection
a–d, Immune cell subsets (a), polar metabolites (b), glycoproteins and lipoproteins (c) and metabolic ratios (d) for each recovery group compared with the HC levels over a year after symptom onset, using mixed modeling. The first 5 × 3 columns indicate the t-statistics obtained for the group effect and corresponding significance after FDR multiplicity adjustment, and the last two columns indicate the significance (−log10 adjusted P value) of the baseline and interaction effects using the group-level longitudinal mixed models.
